Epigenetic intelligence · Animal health

Predicting health before disease.

Vetra Bio combines epigenetic biology, longitudinal data and machine learning to reveal how animal health changes over time, supporting earlier and better-informed decisions.

Built in CambridgeScientific company formation
Veterinary collaborationDesigned with domain expertise
Research partnershipsCross-species data development
Industry engagementFocused on real-world utility
The problem

Disease is often identified after biology has already shifted.

Conventional veterinary care typically detects chronic conditions once meaningful biological change has occurred. Earlier, more continuous insight could help shift care from reactive to proactive.

Technology

Epigenetic biology, longitudinal data and modelling, together.

Our platform is under development to translate molecular signals into interpretable, longitudinal insight about biological state.

Point-in-time testing

  • One reading, one moment
  • Compares to reference ranges
  • Often detects change after it matters

Longitudinal trajectory insight

  • Repeated readings across time
  • Compares each animal to itself
  • Designed to surface change earlier
Platform outputs

Four outputs designed for proactive care.

Our platform is under development to translate epigenetic signals into interpretable, decision-ready insight.

Biological health signals

Multi-layered epigenetic readouts designed to reflect underlying biological state, not just observable symptoms.

Organ-relevant trajectories

Modelling that aims to capture how distinct tissue systems shift over time, rather than a single global score.

Longitudinal monitoring

Repeat measurements over months and years support insight into direction and pace of biological change.

Decision-support insights

Interpretable outputs intended to complement veterinary judgement and inform proactive care planning.

Platform layers

Four layers working together.

01

Data

Curated longitudinal, cross-species datasets designed for biological signal discovery.

02

Biology

Epigenetic measurements selected for informativeness across tissues.

03

Modelling

Machine learning approaches designed to capture direction, pace and context of change.

04

Interpretation

Outputs shaped for veterinary understanding and decision-support workflows.

How it works

From sample to health trajectory.

A staged pipeline connecting biology, data and interpretation.

01

Biological sample

Minimally invasive sampling suitable for routine veterinary workflows.

02

Epigenetic profiling

Molecular signals measured across informative regions of the genome.

03

Computational modelling

Machine learning models trained on longitudinal, multi-species datasets.

04

Health trajectory insight

Interpretable outputs that describe biological direction over time.

Applications

Where our approach can support decisions.

Initial focus areas across species and contexts, developed with domain partners.

01

Equine health

Supporting performance, welfare and long-term monitoring across the working life of the horse.

02

Companion animal health

Enabling earlier biological insight for dogs and cats to inform proactive veterinary care.

03

Veterinary research

Providing cross-species epigenetic tooling to accelerate translational animal health studies.

04

Insurance and population health

Exploring how biological trajectories could inform risk understanding at cohort scale.

Science

Grounded biology. Careful development. Honest communication.

Our scientific work focuses on how epigenetic signals reflect changing biological state, and how those signals can be responsibly translated into decision support.

01

Scientific rationale

Epigenetic patterns shift as tissues respond to internal and environmental signals. These patterns can encode information about biological state that is not visible through conventional testing.

02

Cross-species epigenetics

Conserved methylation biology across mammals enables approaches that generalise across species while respecting species-specific context.

03

Biological resilience

We are interested in signals that reflect the capacity of biological systems to maintain function under stress, not only markers of disease that has already emerged.

04

Validation approach

We follow a staged validation strategy spanning discovery, analytical validation, retrospective analysis, prospective piloting and utility assessment.

05

Responsible development

We communicate our work with care, avoid over-interpretation, and design our tools to support rather than replace qualified veterinary judgement.

Validation roadmap

A staged path from discovery to utility.

We follow a structured validation approach. Progress is described honestly; no clinical or regulatory claims are implied.

Phase 01

Discovery

Signal identification across curated multi-species epigenetic datasets.

Phase 02

Analytical validation

Assessment of measurement reproducibility, precision and robustness.

Phase 03

Retrospective validation

Evaluation against historical longitudinal cohorts.

Phase 04

Prospective pilot

Structured deployment with veterinary and research partners.

Phase 05

Clinical utility assessment

Study of decision-support value in real-world veterinary contexts.

Progress

Building responsibly, step by step.

An honest snapshot of where we are today.

500+
Cross-species datasets curated
Active
Veterinary and research collaborations
In progress
Pilot development
Cambridge
Scientific and entrepreneurial ecosystem
Team

Built by scientists, engineers and operators.

Complementary expertise across epigenetics, multi-omics, machine learning, translational science and commercialisation.

Work with us

Build the future of proactive animal health with us.

We welcome conversations with investors, veterinary partners, researchers and prospective hires.